top of page

On functional disorders and the Rome Criteria. Scientific evidence against the Delphi voting method.

Michael D. Levin MD, Ph.D

published - 22/11/2026

Abstract

​

Background: The Rome criteria classify a broad range of gastrointestinal symptoms as functional disorders after excluding identifiable organic disease. However, the reliability of the diagnostic methods used for this purpose, particularly gastroscopy, pH monitoring, and high-resolution manometry, remains a subject of concern. The Delphi method used to establish the Rome criteria relies on expert consensus rather than scientific evidence. Objective: To critically examine the scientific and pathophysiological foundations of the Rome III–V criteria.

​

Methods: A critical analysis of articles devoted to the Rome criteria was performed from the perspective of scientific knowledge of the anatomy and physiology of the digestive system and formal logic. Radiographic observations are presented in comparison with the results of pH-monitoring and HRM. Results: The differential diagnosis of functional disorders and GERD was based on the notion that pH monitoring is the gold standard for diagnosing GERD, which contradicts numerous scientific data. The conclusions reached through the Delphi process contradicted logic and scientific knowledge of digestive physiology. Conclusions: The analysis of Rome criteria III-V proves the following conclusions: (1)  a lack of logic in the statements; (2) a lack of understanding of the pathophysiology of GERD, where the LES was never mentioned, despite the fact that its damage is key to understanding the symptoms (vomiting, belching, heartburn, pain, etc.); (3) an unfounded claim about esophageal hypersensitivity; (4) a false notion about the diagnostic reliability of pH monitoring, impedance technology, and high-resolution manometry; (5) a lack of evidence that diseases arise from disrupted communication between the gut and the brain; (6) the Rome criteria was not scientific research. Accepting them with such flaws, can only be explained by the fact that the voting participants promoted diagnostic equipment, and drugs for financial gain, at the expense of truth.

​

Keywords: Rome criteria; Delphi method; functional gastrointestinal disorders; GERD; irritable bowel syndrome; functional dyspepsia; hydrochloric acid hypersecretion; pH monitoring; visceral hypersensitivity; gut–brain interaction.

 

 

In previous articles, based on an analysis of the literature and my research, it was proven:

​

(1) The etiology of all acid-dependent diseases (esophagus - GERD; stomach - gastritis, ulcers; duodenum - duodenitis, ulcers; biliary tract - dyskinesia of the sphincter of Oddi and gallbladder, cholelithiasis, cholecystitis) is hypersecretion of hydrochloric acid [1].

​

(2).  Lactose intolerance is probably the most common cause of hydrochloric acid hypersecretion. Lactose triggers the release of histamine from mast cells in the small intestine. Histamine, either directly or by inducing gastrin production, stimulates the secretion of hydrochloric acid in the gastric mucosa [2].

​

(3). The disease often develops in infancy. If an infant with genetic lactose intolerance is given foods that require destruction by hydrochloric acid, the amount of lactase secreted decreases tenfold. Undigested lactose leads to the release of hydrochloric acid. Therefore, during physiological regurgitation of excess milk, the acid enters the esophagus, causing infantile colic. When the stomach capacity increases to the amount needed for a single feeding, the regurgitation ceases, and the infant calms down. However, within 4-6 weeks of the disease, damage to the lower esophageal sphincter occurs, which affects the further progression of the GERD [2].

​

(4). The esophageal wall, unlike the stomach and duodenum, lacks protection from gastric acid. Therefore, GERD symptoms are more pronounced. However, over the years, damage to the stomach, duodenum, and bile ducts occurs, which affects the overall symptoms of the disease. Mucus secretion from the sinuses, pharynx, and esophagus is not a defense mechanism, but a response to inflammation. In terms of quantity and pH, it is not comparable to the volume and pH of the refluxant. No scientific evidence has been published demonstrating the significance of mucus secretion in symptom relief. [3].

​

(5).  Reflux has been shown to begin with the penetration of chyme into the abdominal portion of the LES, before it reaches the esophagus [4]. Therefore, reflux cannot be physiological. The diagnostic value of pH monitoring was not theoretically justified. The normal range (DeMeester score) was determined with methodological flaws. Clinical studies show that false-negative pH monitoring results are at least 30% [5,6]. These include the onset of the disease when acid does not penetrate the esophagus, with an AET <4%, because reflux cannot be physiological, including with an AET >4 and <6.

​

(6). A person can be either healthy or sick. Disease is defined by etiology (cause), pathophysiology (structural changes that lead to dysfunction), and pathogenesis (development of the disease over time). Many patients with acid-related diseases do not experience symptoms despite disease progression. However, if a person suffers from heartburn, abdominal pain, and belching, they are sick. Walker et al showed that the inflammation of the duodenum in functional dyspepsia is characterized by internal inflammation, an eosinophil infiltrate in the duodenum. Emphasizing their adherence to the Rome IV criteria, they conclude that “Thus functional is becoming inflammatory” [7], i.e., fact organic in nature. Are such diseases functional? Can a change in function not be accompanied by structural changes? How do the Rome criteria address these issues?

​

    Characteristics of the Rome Criteria

​

The Rome criteria evolved from Rome I (1994) through Rome V (2026) at gastroenterology meetings using a Delphi vote. Criteria were selected based on publications and were considered true if each criterion received 80% or more. Thus, the Rome criteria do not create new knowledge but rather offer recommendations based on those described in the articles. Secondly, the list of voters is selected by a particular center, allowing for the inclusion of colleagues and like-minded individuals.   This brings subjectivity to the selection of ideas for analysis of recommendations. This also means that Delphi participants' decisions are influenced by their personal professional, career and financial interests.

​

The Rome III criteria described two types of functional disorders: functional dyspepsia (FD) and irritable bowel syndrome (IBS).

​

    Functional dyspepsia (FD) We will trace the dynamics of solutions from Rome III to Rome V criteria. According to the Rome III criteria, FD is characterized by postprandial fullness, early satiety, epigastric pain, or epigastric burning in the absence of organic diseases that explain the patient's symptoms. The Rome III criteria further subdivide FD into postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS). The diagnosis and treatment of this condition remain a clinical dilemma for physicians. A major challenge in defining and, therefore, treating FD is the presence of concomitant reflux disease and IBS in many patients. For example, studies have shown that 37% of patients complaining of dyspeptic symptoms and falling into the EPS category also have esophageal reflux confirmed by pH monitoring, despite normal endoscopy results [8].

​

Analysis. All symptoms described for FD are typical symptoms of GERD. Fullness after meals is pain caused by reflux of gastric contents, when the shortened and weak lower esophageal sphincter (LES) relaxes instead of contracting during increases in gastric pressure. Early satiety is caused by delayed emptying of chyme from the stomach. Therefore, stomach fullness is perceived as satiety. The burning symptom is more accurately called heartburn. By the absence of organic diseases that explain the patient's symptoms is determined, the authors mean the negative results endoscopic examination and pH monitoring. However, endoscopy without histological examination is known to have low diagnostic accuracy for GERD. Meanwhile, the Chicago Classification recommends against mucosal biopsy in the absence of macroscopic pathology. Secondly, pH monitoring underdiagnoses at least 30% of patients with GERD. Thus, there are no scientifically validated methods for excluding organic disease in FD.

​

          Irritable bowel syndrome

​

Irritable bowel syndrome (IBS) was defined by the Rome III criteria as the presence of recurrent abdominal pain or discomfort accompanied by at least two of the following characteristics: (1) relief upon defecation, (2) onset associated with a change in stool frequency, and (3) onset associated with a change in stool form (appearance) [8]. Coexistence of symptoms of FD, IBS and GERD is well documented in the literature. This coexistence is more pronounced in constipation dominant variant of IBS in which patients with FD may experience a feeling of fullness and early satiation. However, in one longitudinal study of patients with IBS and FD, 40% of patients converted their clinical presentation from IBS to FD or vice versa over a 12-year follow-up period [9]. 

​

Analysis. The Rome criteria group symptoms associated with different acid-related diseases into syndromes without adequately considering their underlying pathophysiology. In all patients a change in symptoms (syndromes) is observed during the pathogenesis. All these symptoms are typical features of acid-related diseases. They are defined as functional disorders, not GERD, only because their AET is <4%. It is not clear why patients with FD and IBS, who are diagnosed with GERD, are classified as functional disorders. Reviews of the Rome criteria cite numerous contradictory clinical observations, but the authors unreasonably agree with some of them. Once we abandon the misconception that pH monitoring has some diagnostic value, all the contradictions that contain the Rome criteria will disappear. Patients with the symptoms noted in Figure 1a are the result of hypersecretion of hydrochloric acid, which causes organic damage to the upper part of the digestive system (Figure 1b).

Figure 1.    Diagram (a) from the article by Yarandi et al [8] shows the degree of association between FD, IBS, and GERD. Diagram (b) shows that all these symptoms are symptoms of acid-related diseases.

​

It is important to understand how stool characteristics relate to inflammation in the upper GI tract. As shown by Shafik and El-Sibai, lower esophageal and pyloric sphincter contraction and esophageal and gastric relaxation during rectal distension [10]. I found that the inflammatory process in the appendix is accompanied by an increase in the tone of the digestive tract from the stomach to the anal canal [11]. Thus, the inflammatory process in the esophagus, stomach, and duodenum causes an increase in the tone of all parts of the intestinal tract, including the rectum. It has been established that the defecation reflex is excited by a certain rectal pressure. It is provoked by a certain volume of feces in the rectum [12]. If rectal tone increases, the pressure required to stimulate the defecation reflex is reached with a smaller stool volume. It follows from this that during periods of inflammation, the stool becomes narrow, softer, or liquid, and during periods of remission, the stool is formed and wide. Indian authors identified some differences in the assessment of IBS between the Rome criteria and Asian criteria. In addition, they found that in 636 (39.3%) of 1618 patients, symptoms IBS appeared after ingestion of milk. Of the 593 who stopped consuming milk, 496 (83.8%) reported relief of symptoms [13]. This study confirms that lactose is an etiologic factor in acid-dependent diseases, including so-called IBS, and in fact, organic diseases of the esophagus, stomach, and duodenum.

​

The Rome V criteria describe 10 types of functional disorders, in which organic diseases were excluded using gastroscopy and pH monitoring. There's no logical explanation for why the authors of the Rome V criteria ignore literature demonstrating the low diagnostic accuracy of these methods. Below are typical cases from my practice, proving what is known from the literature (Figure 2).

Figure 2. X-ray examinations of the esophagus, stomach and duodenum in norm and in acid-dependent diseases. (a). Figure 2a shows an example of normal peristalsis of the antral part of the stomach. Every 3rd-5th peristaltic wave close, forming the antral cavity {a}, which is closed proximally by the antral sphincter (yellow arrow). The portion of chyme that the stomach injects into the duodenal bulb through the pyloric sphincter (green arrow) is equal to the capacity of the bulb {b}, which has the shape of an arrowhead [15].

​

 (b). A 19-year-old girl with complaints of heartburn, vomiting and weight loss by gastroscopy was diagnosed GERD. No pathology was found in the stomach and duodenum. It is also known that symptoms worsen after drinking milk.  Allergy to dust and chicken feathers was diagnosed. Longitudinal folds above the stomach (in the LES) indicate an inflammatory process. The antrum of the stomach {a} looks like a straightened tube. The bulb (yellow arrow) has an irregular shape and small volume. The red line in the 3rd part of the duodenum represents the contracted Ochsner sphincter, which contracts during hypersecretion of hydrochloric acid [16].

​

Conclusion: Lactose intolerance and allergies led to hypersecretion of hydrochloric acid, with damage to the esophagus (GERD), stomach (rigid antral gastritis), duodenum (duodenitis) with Ochsner sphincter dyskinesia.

​

(cd). A 75-year-old man had been experiencing heartburn and chest pain intermittently for about 25 years. His condition has worsened in recent months. Since age 70, he has experienced worsening symptoms after consuming lactose-containing products. Taking PPIs temporarily improves symptoms, but worsening returns after relatively large meals, a late dinner, and small amounts of lactose-containing products. Gastroscopy revealed no pathology. (c). X-ray study with a high-pressure in the stomach revealed marked esophageal dilation and significant shortening of the LES, suggesting severe GERD. (d). After 5 minutes, narrowing of the antrum {a} and duodenal bulb deformity was observed (arrow).

​

Conclusion. Lactose intolerance led to hypersecretion of hydrochloric acid, with damage to the esophagus (GERD), stomach (rigid antral gastritis), and duodenum (duodenitis).

​

In each of the three GERD patients who consulted me, in which pH monitoring and HRM were used, the results contradicted the normal and abnormal physiology of the esophagogastric junction (Figure 3).

Figure 3. X-ray examination performed under increased intragastric pressure in patients with GERD in whom GERD was excluded based on pH monitoring or HRM.

​

 (a). A patient with chronic pharyngeal inflammation and hearing loss complains of depression, belching, and a severe cough that worsens during eating and talking. Description: gastroscopy is normal. HRM: LES length is 2.7 cm. Intraabdominal length is 0 cm (Normal LES length is 2.7–4.8 cm). HH is 1.8 cm. Conclusion: The function of the LES is normal. Ambulatory reflux monitoring (pH impedance): Mild increase in acid reflux (pH 4.9%) (AET > 4 but <6). Mean nocturnal baseline impedance is 1.56. Conclusion: Suspected reflux disease is not severe.

​

Analysis of examinations and radiographs. The average length of the LES in the norm is 3.4 cm [5]. Considering that it is impossible to exclude that the control groups include patients with GERD without complaints, it is most likely that the true length of the LES in adults is approximately 4 cm. Therefore, the huge difference between the minimum and maximum normal limits described by HRM indicates low reliability of the HRM. The absence of the intra-abdominal portion of the LES is evidence of damage to the LES. Therefore, the conclusion about the normal function of the LES is erroneous. Radiograph 3a shows typical features of GERD: marked shortening of the LES (0.7 cm versus 3.4 cm) and marked dilation of the esophagus above the LES, representing the ampulla, which is erroneously interpreted as a hiatal hernia. Tortuous asymmetric contours of the esophagus indicate an inflammatory process. Asymmetry of the hypopharynx (h) confirms the fact of an inflammatory process in the pharynx. The statement that an AET of 4.9% is suspicious for mild GERD confirms the well-known fact about low reliability of pH monitoring. This case provides further evidence that gastroscopy cannot rule out GERD. The final diagnosis is non-esophageal form severe GERD.

(b). The patient complained of heartburn and epigastric pain. Sometimes, at night, strong acid enters her mouth. She had been treated for GERD for 20 years. She felt significant symptom relief after swallowing large tablets (2.5 cm in diameter). However, the symptoms returned approximately 4-6 months later. An X-ray revealed a marked shortening of the LES (1 cm versus 3.4 cm) and dilation of the esophagus (ampulla) (3 cm versus 1.5 cm). An asymmetric narrowing is visible above the aortic arch. This is the functional aorto-esophageal sphincter (AES), which occurs because of irritation by hydrochloric acid due to its retention in anatomical narrowing. Contraction of this sphincter at night leads to a retention of acidic chyme between the AES and the upper esophageal sphincter (UES). When the UES relaxes, acid refluxes into the pharynx, causing non-esophageal symptoms of GERD. Taking large tablets stretches the sphincter, resulting in an improvement in symptoms [17]. The patient was referred to a gastroscopy, which revealed no pathological changes. The diagnosis of GERD was not confirmed by pH monitoring based on an AET value of 3.4%.

​

 (cd). A 59-year-old woman complains of frequent heartburn, which first appeared in her youth. Occasionally, she vomits food remnants from the previous day. She regularly takes PPI 20 mg once daily. Heartburn is provoked by a small amount of milk in a cup of coffee. According to HRM, the length of the LES is 3 cm (the norm is 2-4 cm). LES pressure is normal - 28 mm Hg. UES pressure is low. On a radiograph with high gastric pressure (c), a very short and wide LES containing longitudinal folds is observed. Since the actual height of the twelfth thoracic vertebra (D12) is approximately 2 cm, the length of the LES is approximately 1 cm, the width of the ampulla is 3.1 cm, and the width of the esophagus is 2.2 cm. The antrum of the stomach is narrowed and straightened. (d). After 5 minutes, the short LES contains longitudinal folds. The ampulla has decreased in size, and the proximal sphincter is visible between it and the esophagus. The aortic esophageal sphincter is located near the aortic narrowing of the esophagus. Conclusion: Hypersecretion of hydrochloric acid caused by lactose intolerance. Severe GERD with severe esophageal dilation and shortening of the LES, rigid antral gastritis.

​

Gastroscopy is the most common instrumental method, which is prescribed after a long period of ineffective treatment by PPI. However, it can only diagnose complications of GERD: esophageal stenosis, erosions, Barrett's disease and tumors. In addition, it does not diagnose rigid antral gastritis or duodenal dyskinesia, which are evidence of hydrochloric acid hypersecretion and are typically associated with GERD. pH monitoring and HRM are used much less frequently, but in each case, they have led to false conclusions that have had a negative impact on the health of patients.

​

Thus, since a review of the literature and the presented observations demonstrate that gastroscopy, pH monitoring, and HRM have low diagnostic accuracy, they cannot be used as tools to rule out "organic diseases that explain the patient's symptoms" [1]. It follows that patients with typical clinical symptoms of hydrochloric acid hypersecretion, in whom the esophagus, stomach and duodenum are damaged to varying degrees, in whom GERD and irritable bowel syndrome are determined in more than a third of patients, in whom FD at different periods of life turns into IBS or vice versa, in whom a milk-free diet significantly alleviates symptoms, are not functional diseases, since the identification of functional diseases was based on the false assumption that pH monitoring is the gold standard for diagnosing GERD. Since a review of the literature and the presented observations demonstrate that gastroscopy, pH monitoring, and HRM have low diagnostic accuracy, they cannot be used as tools to rule out "organic diseases that explain the patient's symptoms" [1].

​

Let's look at this problem from a different angle. What happens to patients with FGIDs who were treated with imipramine, nortriptyline, citalopram, fluoxetine, melatonin, baclofen prucalopride, domperidone, mirtazapine, cyproheptadine. Neuromodulators can improve mood, pain, diarrhea, constipation, nausea, sleep, and depression [18]. Depression can be controlled with antidepressants, and pain with analgesics, but is this a pathogenetic treatment? Matsumura et al. caution against overestimating the diagnostic capabilities of functional heartburn. The authors found alternative diagnoses after an average of 18.1 months in approximately 20% of patients initially diagnosed with functional heartburn [19]. Longer follow-ups are not yet available. In a study by Caimmi et al., 440 children and adolescents were initially diagnosed with functional gastrointestinal disorders, according to Rome IV criteria. After reassessment 77.9% remained functional 16.5% were reclassified as organic, and 5.4% were classified as mixed. First, the authors did a reassessment, not an examination. Consequently, the criteria were not very convincing. Furthermore, this contradicts the core principle of the Rome criteria, which clearly state that functional disorders are diagnosed after excluding organic diseases [8, 9]. Secondly, the combination of organic diseases and functional disorders contradicts pathological physiology. For example, if a patient is diagnosed with GERD, then vomiting, heartburn, belching, abdominal pain, and constipation, either individually or together, are symptoms of acid-related diseases, including GERD. What kind of combination can we talk about? Thirdly, it is not clear from the article how "Rome IV criteria promote a symptom-based (“positive”) diagnosis of pediatric disorders of gut–brain interaction (DGBIs)" [20].

​

The assertion that patients with functional FGIDs are characterized by resistance to PPI does not make sense because also GERD is not fully controlled by PPI alone [21]. Pharmacotherapy cannot correct anatomical abnormalities or eliminate the structural causes of GERD [22], such as a short and weak LES. Acid-suppressing therapy will not help unless provocateurs of hydrochloric acid hypersecretion are eliminated from the diet and the diet is modified. Therefore, some patients are offered surgical treatment.

​

   Rome IV&V criteria about esophageal hypersensitivity and gut–brain interaction

​

In 2026, a new version was published: Rome V Pediatric Upper Gastrointestinal Disorders Related to Gut-Brain Interface [14]. The core principles of the Rome V criteria for describing "functional" disorders in children are fully consistent with those for adults, so most references refer to articles devoted to adults. Basic principles of RomeV criteria: (1) Visceral hypersensitivity is recognized as a cause of functional gastrointestinal disorders. (2) There is also a role for gut-brain interaction in symptom perception (Disorders of Gut-Brain Interface - DGBI). (3) pH monitoring and esophageal impedance-pH monitoring serve as the gold standard for both theoretical justification and definitive diagnosis. The authors describe 10 functional disorders. Let us analyze the research methodology using the example of Reflux-Negative Esophageal Pain Disorder Pathophysiology (RNEPD).

​

Reflux-Negative Esophageal Pain Disorder includes retrosternal pain, heartburn or throat pain or burning sensation in the throat with normal macroscopic esophageal findings on endoscopy and absence of histologic evidence of eosinophilic esophagitis, as well as normal esophageal acid exposure on pH- or pH-impedance monitoring [14].

​

Interestingly, "Reflux hypersensitivity" includes retrosternal pain, heartburn, throat pain or burning sensation in the throat with normal macroscopic esophageal findings on endoscopy and absence of histologic evidence for eosinophilic esophagitis, evidence of triggering of symptoms by acid and/or non-acid reflux events on pH- or pH-impedance monitoring despite normal acid exposure [14].

​

   First, there are no differences in the descriptions of symptoms of RNEPD and reflux hypersensitivity.

​

   Second, in the description of "Pathophysiology" acknowledges that it is multifactorial and lists assumptions that have nothing to do with physiology.

​

  Third, the authors treat pH monitoring as the gold standard for GERD diagnosis, ignoring numerous reliable studies that pH monitoring underdiagnoses at least 30% of patients with GERD. From the point of view of scientific evidence, pH monitoring has no diagnostic value, since it was developed on the false assumption of the possibility of functional reflux. Just as there is no functional reflux, there cannot be functional disorders.

​

   Fourth, the authors suggest "that visceral hypersensitivity likely plays a main pathogenetic role as these patients have intact mucosal integrity, normal mucosal".   At the same time, they claim that "the presence of microscopic esophagitis does not preclude a diagnosis of RNEPD as 20%–23% of children with RNEPD had microscopic esophagitis which did not correlate with symptom severity" [14].

​

   Fifth, the assertion that esophageal hypersensitivity exists is not supported by scientific data. This is not only because pH monitoring does not rule out GERD, but also because numerous studies have shown that GERD is often diagnosed by endoscopy in patients without clinical manifestations. For example, according to Swedish researchers, "gastroesophageal reflux symptoms and erosive esophagitis were detected during gastroscopy in one-third of the asymptomatic Swedish adult population [23].

​

  Sixth, these studies not only prove that acid-related diseases are characterized by hyposensitivity even with erosive esophagitis but also show no correlation between the severity of the lesion and the symptoms. Thus, the lack of correlation between the degree of esophageal mucosal damage and symptoms does not prove hypersensitivity.

​

   Seventh, moreover, microscopic esophagitis is an inflammatory infiltration by lymphocytes and eosinophils, which is evidence of reflux esophagitis. As studies by several groups of authors have shown, only the expansion of the intercellular space showed a high accuracy in the diagnosis of GERD. A review article by Dent states that "Dilation of intercellular spaces was the most consistently reported histologic change in the esophageal mucosa of patients with nonerosive reflux disease. The mean intercellular space width was at least 2 times greater in patients than in controls, irrespective of esophageal acid exposure" [24]. Thus, histological studies indicate structural, i.e. organic damage to the wall of the esophagus.

​

   Eighth, the authors of the Rome V criteria cite one pediatric study showing that 25–75% of patients experienced partial or complete resolution of symptoms in response to PPIs. However, Delphi participants believe that the response to acid suppression may be a placebo effect, as RNEPD is not caused by acid reflux. Since RNEPD falls within the spectrum of visceral hypersensitivity, neuromodulators should be the mainstay of therapy [14]. This explanation not only contradicts logic, but also the recommendations for the treatment of reflux hypersensitivity, which state that an empiric PPI trial is often an initial step for typical symptoms such as heartburn or chest pain, should be time-limited up to 8 weeks [14].

​

If we take a logical approach to the facts presented in the eight statements above, it becomes obvious that there is no evidence of esophageal hypersensitivity. Just as reflux cannot be physiological, the symptom complexes that are called functional damage are GERD, often in combination with other acid-dependent diseases. Omura et al., using pH monitoring, found GERD in only about 20% of the patients with typical clinical presentation of GERD [25]. It is likely that the reliability of pH monitoring in the diagnosis of GERD is close to this figure because it: (1) cannot determine the onset of the disease when acid washes only the abdominal part of the LES; (2) when it defines cases with AET <4% as physiological reflux; when it considers the range of AET >4% - <6% questionable in the diagnosis of GERD.

​

 As evidence of disorders of gut brain interaction, the authors cite three articles devoted to the influence of stress on the perception of clinical symptoms of GERD in adults.

​

In an article by Fass et al., the authors demonstrated the high value of the Bernstein test in diagnosing GERD. Furthermore, they showed that acute auditory stress can worsen heartburn symptoms in patients with GERD [26].   Nalebuff et al. found that heartburn severity appears to be most sensitive to significant life events. They suggested that the mechanisms include increased levels and frequency of esophageal acid exposure, delayed gastric emptying of acid, or stress-induced hypersensitivity [27]. Wright et al. found that the stressor resulted in increased cortisol levels and state anxiety; however, this was not associated with the occurrence of reflux [28].

​

An analysis of articles purporting to support disorders of gut-brain interaction in functional gastrointestinal diseases reveals the following: (1) Adult patients with GERD, not functional disorders, were examined. (2) Only one article suggested stress-induced hypersensitivity, not disorders of gut-brain interaction. There was no hint of evidence that the connection between the gut and the brain could be disrupted.

​

Meanwhile, the study by Jones et al. demonstrates that heartburn confers a significant burden on patients with GORD, related to the frequency and severity of symptoms and reflected in the reduction in HR-QOL as perceived by the patients [29]. It's logical to assume that anxiety and depression arise because of chronic illness, reducing the patient's well-being and quality of life.

​

A person evaluates his state of his body as a sensation, in a result of the connection between its organs and the brain. It's well known that stressful situations can trigger myocardial infarction, but this occurs due to vasospasm, not a disruption in the connection between the brain and the heart. Thus, the fact that we experience pain, as well as the results of all sensory activity, is a result of the connection between all parts of the body and the brain. However, there is no evidence that disruption of the connection between the body and the brain causes pathology in any organ.

Two platforms, the Rome Criteria and the Chicago Classification, use the Delphi method to promote ideas unsupported by scientific research. The decisions of these groups make no reference to physiological laws established over several centuries. The participants in these voting processes are effectively creating a new gastroenterology from scratch, relying primarily on modern diagnostic equipment, the standards for which were developed in defiance of the physiology of the digestive system. This was initiated by the creation of the DeMeester score, which contradicted scientific data because it asserted the possibility of physiological reflux without scientific evidence. The idea that pH monitoring is the gold standard in diagnosing GERD led to the widespread use of this method. However, since the method was not scientifically validated, a large group of patients with typical GERD symptoms with pH <4% emerged. In order not to compromise pH monitoring, the authors began to explain these objective data by the presence of functional disorders (initially FD and IBS), the pathophysiology of which was allegedly caused by esophageal and intestinal hypersensitivity.

 

Over time, numerous articles appeared demonstrating that at least 30% of patients with endoscopic evidence of GERD had a pH <4%. This evidence did not change the decisions of the Rome criteria and Chicago Classification. This can only be explained by the fact that device manufacturers reaped enormous profits, and Delphi voting participants received financial compensation, which they disclosed in the "Conflict of Interest" section of each article. Rome criteria IV introduced the unfounded idea of ​​a disrupted connection between the brain and the gut, based on which supposedly functional disorders should be treated with drugs that could supposedly restore this lost connection. This led to the emergence of numerous medicines, for the promotion of which voting participants received further financial subsidies.

​

A PubMed search for "Gut-Brain Interaction" yields 4,554 references. Surprisingly, in my practice of gastroenterology, I have never encountered patients diagnosed with functional disorders or Gut-Brain Interaction disorders. However, every department has all the available equipment, as a gastroenterologist's career advancement depends on the number of publications, which are impossible without reference to the use of modern equipment. Thus, in modern gastroenterology, there are two levels. The practical outpatient level, in which GERD is diagnosed based on clinical symptoms and gastroscopy. The use of diagnostic equipment is carried out in hospital settings or in diagnostic centers. This option ensures maximum sales of equipment, which, as shown above, has low diagnostic accuracy. As shown in the article by Omura et al., using pH monitoring, GERD was found in only about 20% of the patients with typical clinical presentation of GERD [25].

​

The justification for the existence of functional gastrointestinal disorders, and the diagnosis of their various forms is based on pH monitoring, impedance technology, and high-resolution manometry, the actual accuracy of which is approximately 20%. Why was this article published in the journal "Gastroenterology" if every conclusion the authors make contradicts formal logic, i.e., common sense? Why was the article published despite a conflict of interest? The authors stated: "The authors have no relevant disclosures." However, "no relevant" means that the authors conceal financial relationships with equipment and drug manufacturers. For example, M. Benninga is a consultant for Shire, Norgine, Coloplast, Danone, Takeda, Allergan, Friesland Campina, United Pharmaceuticals, and HiPP. (2025); Nurko is a consultant for IHS. So, whose interests do the authors of the Rome V criteria protect?

 

 

Conclusion 

The analysis of Rome criteria III-V leads to the following conclusions: (1)  a lack of logic in the statements;(2) a lack of understanding of the pathophysiology of GERD, where the LES was never mentioned, despite the fact that its damage is key to understanding the symptoms (vomiting, belching, heartburn, pain, etc.); (3) an unfounded claim about esophageal hypersensitivity; (4) a false notion about the diagnostic reliability of pH monitoring, impedance technology, and high-resolution manometry; (5) a lack of evidence that diseases arise from disrupted communication between the gut and the brain; (6) the Rome criteria is not scientific research. Accepting them with such flaws, can only be explained by the fact that the voting participants promoted diagnostic equipment, and drugs for financial gain, at the expense of truth.

References

​​​​

  1. Levin MD. Hydrochloric acid hypersecretion is the cause of pathology of the upper digestive tract. Literature analysis. 8 January 2025, Preprint v1 · CC-BY 4.0. doi.org/10.32388/4QXH2Q

  2. Levin MD. (2025). Pathogenesis of Infantile Colic. Hypothesis. Mathews J Gastroenterol Hepatol. 10(1):29. https://doi.org/10.30654/MJGH.10029

  3. Levin MD. (2025). Prevention and Treatment of Esophageal Reflux Disease: Literature Analysis. Mathews J Gastroenterol Hepatol. 10(2):33. https://doi.org/10.30654/MJGH.10033

  4. Chandrasoma P, DeMeester T. A New Pathologic Assessment of Gastroesophageal Reflux Disease: The Squamo-Oxyntic Gap. Adv Exp Med Biol. 2016;908:41-78. doi: 10.1007/978-3-319-41388-4_4. PMID: 27573767.

  5. Levin MD. (2025). X-Ray Imaging of the Esophagus and Lower Esophageal Sphincter and Its Role in the Diagnosis of Gastroesophageal Reflux Disease. Mathews J Gastroenterol Hepatol. 10(2):31.

  6. Tseng D, Rizvi AZ, Fennerty MB, et al. Forty-eight-hour pH monitoring increases sensitivity in detecting abnormal esophageal acid exposure. J Gastrointest Surg. 2005 Nov;9(8):1043-51; discussion 1051-2. doi: 10.1016/j.gassur.2005.07.011.  

  7. Walker MM, Talley NJ. The Role of Duodenal Inflammation in Functional Dyspepsia. J Clin Gastroenterol. 2017 Jan;51(1):12-18. doi:10.1097/MCG.0000000000000740.

  8. Yarandi SS, Christie J. Functional Dyspepsia in Review: Pathophysiology and Challenges in the Diagnosis and Management due to Coexisting Gastroesophageal Reflux Disease and Irritable Bowel Syndrome. Gastroenterol Res Pract. 2013;2013:351086. doi: 10.1155/2013/351086.  

  9. Schmulson MJ, Drossman DA. What Is New in Rome IV. J Neurogastroenterol Motil. 2017 Apr 30;23(2):151-163. doi: 10.5056/jnm16214.

  10. Shafik A, El-Sibai O. Esophageal and gastric motile response to rectal distension with identification of a recto-esophagogastric reflex. Int J Surg Investig. 2000;1(5):373-9.

  11. Levin MD. The increased intestinal tone in acute appendicitis is an example of a reaction to local inflammation. Hypothesis. Pelviperineology. 2023;42(3):120-124. DOI: 10.34057/PPj.2022.42.03.2022-6-6.

  12. Levin MD. Anatomy and physiology of anorectum: the hypothesis of fecal retention, and defecation. Pelviperineology 2021;40(1):50-57. DOI: 10.34057/PPj.2021.40.01.008

  13. Ghoshal UC, Abraham P, Bhatia SJ,  et al. Comparison of Manning, Rome I, II, and III, and Asian diagnostic criteria: report of the Multicentric Indian Irritable Bowel Syndrome (MIIBS) study. Indian J Gastroenterol. 2013 Nov;32(6):369-75. doi: 10.1007/s12664-013-0365-7.  

  14. Rosen R, Borrelli O, Faure C, et al . Rome V Pediatric Upper Gastrointestinal Disorders of Gut-Brain Interaction. Gastroenterology. 2026 May;170(6):1347-1366. doi: 10.1053/j.gastro.2026.01.039. 

  15.   Levin MD, Korshun Z, Mendelson G. GASTRIC MOTILITY HYPOTESIS. Eksp Klin Gastroenterol. 2016;(10):104-112. English, Russian. PMID: 29889384.

  16. Levin MD (2023) Hypersecretion of Hydrochloric Acid as a Cause of Superior Mesenteric Artery Syndrome – Review. JSM Gastroenterol Hepatol 10(1): 1117.

  17. Levin MD. Aorto-Esophageal Sphincter and its role in the pathogenesis of the gastroesophageal reflux: cases report and analysis. Gastroenterol Hepatol Open Access. 2025: 16 (1):-1-8.

  18. Sobin WH, Heinrich TW, Drossman DA. Central Neuromodulators for Treating Functional GI Disorders: A Primer. Am J Gastroenterol. 2017 May;112(5):693-702. doi: 10.1038/ajg.2017.57. Epub 2017 Mar 28. PMID: 28349992.

  19. Matsumura T, Sonoda M, Suzuki T, et al. Limitations of 24-hour MII-pH monitoring to diagnose functional heartburn: a diagnostic reassessment. Dis Esophagus. 2026 Mar 2;39(2):doag034. doi: 10.1093/dote/doag034.

  20. Caimmi S, Licari A,  Di Carlo A< et al. Diagnostic Revision and Organic Disease Risk in Pediatric Rome IV Disorders of Gut–Brain Interaction: A Single-Center Retrospective Cohort. Gastrointest. Disord. 2026, 8, 21. doi.org/10.3390/gidisord8020021.

  21. Lee JY, Kim SE, Shin JE, et al; Diet, Obesity, and Metabolism Research Study Group under the Korean Society of Neurogastroenterology and Motility. [Gastroesophageal Reflux Disease]. Korean J Gastroenterol. 2025 Oct 25;85(4):440-450. Korean. doi: 10.4166/kjg.2025.115. 

  22. Kasugai K, Ogasawara N. Gastroesophageal Reflux Disease: Pathophysiology and New Treatment Trends. Intern Med. 2024 Jan 1;63(1):1-10. doi: 10.2169/internalmedicine.1551-23. 

  23. Ronkainen J, Aro P, Storskrubb T et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report. Scand J Gastroenterol. 2005;40:275–285

  24. Dent J. Microscopic esophageal mucosal injury in nonerosive reflux disease. Clin Gastroenterol Hepatol. 2007 Jan;5(1):4-16. doi: 10.1016/j.cgh.2006.08.006.

  25.  Omura N, Kashiwagi H, Yano F, et al. Characteristics of symptomatic GERD in Japanese patients based on 24-h pH monitoring. J Gastroenterol. 2005 Aug;40(8):791-5. doi: 10.1007/s00535-005-1629-5.  

  26. Fass R, Naliboff BD, Fass SS, et al. The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease. Gastroenterology. 2008 Mar;134(3):696-705. doi: 10.1053/j.gastro.2007.12.010.  

  27. Naliboff BD, Mayer M, Fass R, et al. The effect of life stress on symptoms of heartburn. Psychosom Med 2004;66:426–34.  

  28.  Wright CE, Ebrecht M, Mitchell R, et al. The effect of psychological stress on symptom severity and perception in patients with gastro-oesophageal reflux. J Psychosom Res 2005;59:415–24.  

  29. Jones R, Horbach S, Sander P, Rydén-Bergsten T. Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of disease. Pharmacoeconomics. 2003;21(15):1091-102. doi: 10.2165/00019053-200321150-00003. 

© 2015 Created by Dr. Levin Michael

bottom of page